Gastric cancer remains the fifth most common cancer globally, posing a formidable challenge due to its often late diagnosis and poor prognosis. Remarkably, early-onset cases, defined as those occurring at a younger age, constitute approximately 10% of total gastric cancer incidents. This demographic shift demands a nuanced understanding, as younger patients frequently exhibit distinct clinical and genetic profiles influencing disease progression and treatment responses.

The investigative team employed advanced statistical modeling, including joinpoint regression analysis, to rigorously evaluate temporal trends from 1990 through 2021. Their focus on the 11 BRICS nations—Brazil, Russia, India, China, South Africa, and six additional emerging economies—reflects a strategic choice to explore regions undergoing rapid demographic, socioeconomic, and environmental transitions that may impact cancer epidemiology.

Key findings reveal a substantive decline in absolute EOGC cases by nearly 12% and a more pronounced reduction of over 33% in disability-adjusted life years (DALYs) over the study period. Such decreases might suggest improvements in cancer control policies or shifts in risk factor exposures, although the burden remains unevenly distributed. Notably, China and India represent the epicenters of absolute case counts, whereas the United Arab Emirates maintains the lowest reported burden.

Age-standardized rates (ASRs) unveil further complexities. China and Russia exhibit the highest incidence and burden rates, correlating with environmental exposures and lifestyle factors prevalent in these regions. Contrastingly, the UAE’s lower ASRs raise intriguing questions about potential protective factors or differences in healthcare access and reporting accuracy.

The study emphasizes pronounced gender disparities, with males generally exhibiting a higher EOGC burden except in Ethiopia, the UAE, and Saudi Arabia where this pattern does not hold. These differences may reflect divergent behavioral risk factors, such as smoking prevalence and dietary habits, necessitating targeted interventions.

Temporal trend analysis uncovers predominantly declining ASRs across most nations, a beacon of progress linked to improved public health measures and possibly heightened awareness and earlier diagnosis. Egypt emerges as an anomaly with a slight uptick in age-standardized incidence and DALY rates, signaling an urgent need for focused healthcare strategies in this region.

A notable discovery involves transient surges in incidence observed in South Africa and Saudi Arabia during specific intervals, underscoring the dynamic nature of cancer epidemiology shaped by socio-political, environmental, or healthcare system changes.

Investigations into health inequalities reveal persistent disparities concentrated within higher socio-demographic index (SDI) countries. Although absolute inequalities are statistically insignificant, the sustained relative gaps highlight the imperative for equitable healthcare delivery and resource allocation.

Population dynamics play a pivotal role in shaping epidemiological trends. For most BRICS nations, population growth and aging significantly drive upward burden trends. However, China and Russia mainly experience changes due to population growth, whereas aging is more influential in Ethiopia, highlighting the heterogeneous demographic influences on disease patterns.

The interplay between risk factors and disease burden emerges vividly through decomposition and exposure analyses. Smoking consistently ranks as a leading modifiable risk factor, with variable population attributable fractions (PAFs) across countries. The Russian Federation and China report the highest smoking-associated risks, linked to increasing summary exposure values (SEVs), reflecting worsening risk profiles or improved risk exposure estimations.

Dietary factors, particularly high sodium consumption, remain a steadfast concern. India and Ethiopia register peak PAFs for high-sodium diets coupled with increasing exposure, a combination that perpetuates gastric carcinogenesis risk. These insights underscore the urgency of integrating nutritional policy reforms into cancer prevention frameworks.

Crucially, projections to 2035 anticipate an overall continued decline in EOGC burden nationally within the BRICS countries. Yet, these predictions paradoxically highlight South Africa’s potential rise to the second-highest age-standardized DALY rate, a trend warranting intensified surveillance and intervention efforts.

The study’s methodological rigor is further enhanced by sensitivity analyses employing the Nordpred model, substantiating the robustness of the Bayesian age-period-cohort (BAPC) model projections and providing policymakers with reliable foresight for strategic planning.

This comprehensive evaluation reveals that despite encouraging declines in EOGC burden, the BRICS nations face disparate epidemiological realities. Higher-SDI countries and male populations bear disproportionate disease loads, underscoring the critical necessity for demographically tailored preventive measures.

The identification of smoking and high-sodium diets as principal modifiable risk factors offers actionable targets for health authorities. Coordinated regional strategies focused on tobacco control and nutritional interventions can significantly mitigate the EOGC burden.

Looking ahead, strengthening regional collaboration among BRICS countries is paramount. Shared expertise, harmonized data systems, and unified prevention campaigns can streamline efforts to curb EOGC, enhancing outcomes through resource synergy and policy coherence.

Furthermore, improved surveillance mechanisms are essential to detect emerging trends, evaluate intervention efficacy, and adapt strategies dynamically, ensuring sustained progress against early-onset gastric cancer.

The comprehensive nature of this analysis not only illuminates the evolving landscape of EOGC within critical emerging economies but also establishes a replicable framework for future cancer burden studies in similar global contexts.

In sum, the pioneering research underscores an urgent call to action—integrating epidemiological insights with public health innovation—to confront the nuanced challenges of early-onset gastric cancer and safeguard future generations across the BRICS nations.

Subject of Research: Epidemiology, burden, and risk factors of early-onset gastric cancer in the 11 BRICS countries with projections to 2035.

Article Title: Burden and trends of early-onset gastric cancer in the 11 BRICS countries (2025 expansion): 1990–2021 with projections to 2035.

Article References:
Li, X., Wang, J., Ma, Y. et al. Burden and trends of early-onset gastric cancer in the 11 BRICS countries (2025 expansion): 1990–2021 with projections to 2035. BMC Cancer 25, 1478 (2025). https://doi.org/10.1186/s12885-025-14923-1

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14923-1

Lip and oral cavity cancer remains one of the most prevalent malignancies affecting the elderly, a demographic particularly vulnerable due to age-related physiological changes and comorbidities. Despite its significant impact, systematic appraisals focusing on this age group have been sparse, leaving policymakers and clinicians without adequate data to guide intervention and resource allocation effectively. Liu and Han’s study addresses this critical gap by adopting a global perspective combined with regional and national granularity, highlighting disparities and trends with striking clarity.

The study harnesses key epidemiological metrics such as the age-standardized incidence rate (ASIR), prevalence rate (ASPR), mortality rate (ASMR), and disability-adjusted life years (DALYs, quantified here as ASDR) to map out the burden of LOCC. These metrics, standardized for age, allow comparisons across diverse populations and temporal frames, eliminating confounding effects of demographic shifts. From 1990 to 2021, the ASIR climbed to 23.13 cases per 100,000 elderly individuals, while prevalence reached 72.19 per 100,000 – indicative of more elderly people living with the disease. Mortality and DALYs, registering at 12.57 and 253.10 per 100,000 respectively, reflect the lethal and disabling impact of LOCC in this population over the study period.

One of the study’s most compelling revelations is the complex relationship between socioeconomic development and disease burden. By stratifying data according to the Social Development Index (SDI), the authors demonstrate that higher SDI regions experienced rising incidence and prevalence, likely reflecting enhanced diagnostic capabilities, better healthcare access, and increased life expectancy which collectively raise the detection and reporting of cases. Conversely, mortality and DALYs rates decreased in these regions, signaling improvements in treatment efficacy and survivorship. This dichotomy offers a hopeful glimpse into how advancements in healthcare infrastructure and public health interventions can modulate cancer outcomes even as incidence rises.

The global narrative, however, is not uniform. The absolute and relative health inequalities in LOCC burden between countries have shown a gradual reduction, marking a significant step toward equity. Yet, regional discrepancies persist, with certain low and middle SDI regions enduring disproportionately high mortality and disability ranks. These disparities illuminate the ongoing challenges related to healthcare access, early diagnosis, and effective treatment that continue to hamper progress in the fight against LOCC.

Gender and age also emerge as critical determinants in disease burden. The study notes a consistently higher burden in males compared to females, a trend attributed in part to behavioral risk factors such as tobacco chewing, alcohol consumption, and smoking which remain entrenched in many societies and disproportionately affect men. Age-related increases in LOCC burden emphasize the need for vigilance and tailored interventions as the global population ages, recognizing that elderly individuals bear a compounded risk of developing and succumbing to this malignancy.

Liu and Han’s projections for the period between 2022 and 2050 forecast a continued rise in the age-standardized rates of LOCC among the elderly. This sobering outlook underscores an urgent call to action for the medical community and public health officials worldwide. Without targeted efforts to mitigate modifiable risk factors, increase early detection, and improve access to care, the human and economic toll of LOCC is poised to escalate in tandem with demographic shifts toward aging populations.

Importantly, the study validates the predominant risk factors associated with LOCC in the elderly as chewing tobacco, high alcohol consumption, and smoking. These behavioral determinants remain common in many parts of the world and are critical targets for cancer prevention campaigns. The persistence of these risk factors suggests that despite advances in treatment technologies, primary prevention via behavior modification and public health messaging remains a cornerstone in reducing the disease burden.

The epidemiological sophistication of this research is notable. By segmenting the global population into five distinct SDI regions and further refining analyses across 21 GBD-defined regions, the authors achieve a granular understanding of the disease’s dynamics that surpasses most prior investigations. This methodical approach allows for identification of hotspot regions where LOCC exerts excessive burdens, informing localized health policy formulation and targeted resource deployment.

Another salient feature of the findings is the noted slowdown in the growth rate of LOCC burden in recent years. While the absolute numbers continue to increase, the deceleration possibly reflects the gradual impact of improved public health interventions, early screening programs, and better clinical management. It also may indicate saturation effects in older age groups or shifts in population risk profiles. Nonetheless, the overall upward trajectory is clear, necessitating sustained and enhanced efforts.

The worsening burden of LOCC also places enormous strain on healthcare systems, particularly in developing regions grappling with limited oncology services. High mortality and disability rates translate into increased demand for palliative care, rehabilitation services, and social support structures that often remain underdeveloped. Highlighting these challenges, this research champions the imperative to integrate cancer control within broader aging and chronic disease management frameworks.

This study also underscores the importance of standardized global data collection platforms such as GBD for monitoring cancer trends. Continuous updates to such databases and methodological refinements remain essential in capturing the evolving cancer burden landscape and evaluating the effectiveness of interventions. The authors’ work not only contributes to this evidence base but also exemplifies the critical role of big data analytics in contemporary epidemiology.

Furthermore, the implication of ongoing health inequalities in LOCC burden hints at socioeconomic determinants of health that transcend biology. Factors such as education, income disparity, cultural norms around risk behaviors, and healthcare accessibility intertwine to shape outcomes. Addressing these structural determinants is as vital as biomedical innovation in curbing the increasing toll of oral cancers in elderly worldwide.

In conclusion, Liu and Han’s landmark analysis offers a sobering yet insightful panorama of lip and oral cavity cancer in the elderly, revealing a persistent increase in incidence, prevalence, and impact despite some encouraging signs of slowing growth rates and declining mortality in higher SDI regions. The research reinforces the necessity for continued investment in preventive public health initiatives targeting tobacco and alcohol use, early diagnosis, and equitable access to cancer care. It further spotlights the nuanced interplay between age, gender, region, and socioeconomic factors in shaping disease burden, guiding future global and local strategies to combat this challenging cancer.

As the world population ages, the rising tide of lip and oral cavity cancer among seniors demands urgent, coordinated action across clinical, community, and policy spheres. The study by Liu and Han serves as a clarion call to harness the converging forces of data science, medicine, and social policy to mitigate this growing public health threat and enhance longevity and quality of life for millions of elderly individuals worldwide.

Subject of Research: Burden trends and epidemiology of lip and oral cavity cancer among individuals aged 60 and above.

Article Title: Global, regional, and national burden trends of lip and oral cavity cancer among individuals aged 60 and above from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease data.

Article References: Liu, Y., Han, B. Global, regional, and national burden trends of lip and oral cavity cancer among individuals aged 60 and above from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease data. BMC Cancer 25, 1322 (2025). https://doi.org/10.1186/s12885-025-14768-8

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14768-8